Guangzhou Kingmed Diagnostics Group Co.,Ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Guangzhou Jinyu Medical Laboratory Group Co., Ltd. [stock code: 603882] is a high-tech service enterprise with third-party medical laboratory and pathological diagnosis business as its core. Through continuously accumulating core resource advantages such as "big platform, big network, big service, big sample, and big data", we are committed to providing leading medical diagnostic information integration services for medical institutions at all levels nationwide. The core entrepreneurial team of Jinyu Medical has been actively exploring the operation mode of medical laboratory outsourcing services in China since the 1990s, pioneering the domestic third-party medical laboratory industry. After years of development, it has now become a market leader in the domestic third-party medical laboratory industry. Jinyu Medical strictly follows international standards and has an advanced quality management system. As of 2021, a total of 47 domestic and international certification and recognition certificates, including CAP and ISO15189 from the United States, have been obtained, leading the industry for 19 consecutive years. The test results are recognized by 70 countries and regions worldwide. With excellent quality management, Jinyu Medical has won the "Nomination Award for the 4th China Quality Award" and the "Nomination Award for the 19th National Quality Award". Jinyu Medical has established 39 medical laboratories in mainland China, Hong Kong, and Macau through business model innovation. It has a remote pathological collaboration network covering the country, as well as a team of pathologists composed of over 630 domestic and foreign pathologists, providing accurate, timely, and convenient medical examination and pathological diagnosis services to over 23000 medical institutions. The service network covers more than 90% of the country's population, and takes Hong Kong as the bridgehead to serve the Guangdong Hong Kong Macao Greater Bay Area and countries and regions along the "the Belt and Road". By connecting with international and independent innovation, achievement transformation, and other means, Jinyu Medical can provide over 3000 testing projects. The annual number of tested specimens exceeds 150 million, accumulating the world's leading Oriental large sample and database, and based on this, promoting the original innovation of in vitro diagnosis industry and artificial intelligence diagnosis. The company focuses on building international and high-end talents and teams, with over 1200 scientific researchers and over 200 well-known experts at home and abroad, including more than 30 scholars returning from overseas. It has established Academician Zhong Nanshan as the chairman, and 8 academicians Zeng Yitao, Chen Runsheng, Hou Fanfan, Xie Xiaoliang, Chen Yeguang, Zhang Xue, Tan Weihong, and Li Xiaokun as consultants, with a total of 52 domestic and foreign laboratory and pathological examinations A Golden Domain Medical Academic Committee composed of authoritative experts in clinical and other industries. Jinyu Medical has a globally leading renal disease ultramicro pathological diagnosis center, a respiratory virus diagnosis research center that connects with national platforms, and has been recognized as a national high-tech enterprise, a national genetic testing technology application demonstration center, a national intellectual property demonstration enterprise, and a national public technology service demonstration platform for small and medium-sized enterprises. It has been approved to establish a national and local joint engineering laboratory for medical testing technology and services National, provincial, and ministerial level research and development institutions and platforms, including national postdoctoral research workstations, Guangdong Provincial Academician workstations, and Guangdong Provincial Enterprise Key Laboratories. At present, Jinyu Medicine is focusing on third-party medical examination as the main channel, striving to build a "medical examination+" ecosystem through large technology platforms, large service networks, and large samples and databases: accelerating the application of large samples and big data in medical examination technology innovation and artificial intelligence; At the same time, we will continuously improve the development of related industries such as clinical drug trials, health inspections, health examinations, and judicial appraisal. Adhering to the principles of professionalism and technology, adhering to the essence of medical care and the bottom line of the industry, being kind and benevolent, striving for the welfare of society and the public, and creating a better life together, Jinyu Medical uses practical actions to assist a healthy China. |
| Headquarter | Guangzhou |
| Establish Date | 5/26/2006 |
| Listed Code | 603882.SH |
| Listed Date | 9/8/2017 |
| Chairman | Liang Yaoming. |
| CEO | Liang Yaoming. |
| Website | www.kingmed.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
